Avalon Pharmaceuticals to Present at 24th Annual JPMorgan Healthcare Conference

GERMANTOWN, Md., Jan. 4  /PRNewswire-FirstCall/ -- Avalon Pharmaceuticals, Inc. (Nasdaq and ArcaEx(R): AVRX), a biopharmaceutical company focused on the discovery and development of small molecule therapeutics, today announced that Kenneth C. Carter, Ph.D., President and CEO is scheduled to provide an update on the Company at the 24th Annual JPMorgan Healthcare Conference.

The conference will be held at the Westin St. Francis in San Francisco on January 9-12, 2006.  Dr. Carter is scheduled to present on Thursday, January 12th at 2:00 p.m. Pacific Time (11:00 p.m. Eastern).

The presentation will be available live via a webcast and can be accessed through Avalon Pharmaceuticals' website at: http://www.avalonrx.com/.  An archive of the presentation will be available for replay following the conference.

About Avalon Pharmaceuticals, Inc.

Avalon Pharmaceuticals is a biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Avalon seeks to discover and develop novel therapeutics through the use of a comprehensive, innovative and proprietary suite of technologies based upon large-scale gene expression analysis which it calls AvalonRx(R). Avalon Pharmaceuticals was established in 1999 and is headquartered in Germantown, Maryland.

  Contacts:
  Avalon Pharmaceuticals, Inc.           Noonan Russo
  Gary Lessing                           Wendy Lau (Media)
  Chief Financial Officer                Tel: [phone]
  Tel: [phone]
  Fax: [phone]                    Jane Petrino (Investors)
  Email:                Tel: [phone]


DATASOURCE: Avalon Pharmaceuticals, Inc.



CONTACT:  Gary Lessing, Chief Financial Officer, Avalon Pharmaceuticals,

Inc., [phone], Fax: [phone], ; Wendy Lau

(Media), [phone], or Jane Petrino (Investors), [phone], both

of Noonan Russo



Web site:  http://www.avalonrx.com/ 

Copyright